The efficacy of a harm reduction intervention for androgen abuse: a historically controlled trial
European Journal of Endocrinology · 04.02.2026 · 194 (2) · 69-79
DOI: 10.1093/ejendo/lvag002 ↗Kurz gefasst
Kontrollierte klinische Studie in der Zeitschrift European Journal of Endocrinology, online erschienen am 13.01.2026. Verfasst von Tijs Johannes Verdegaal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Spaarne Gasthuis, Boerhaavelaan 22, Haarlem 2035 RC, the Netherlands. Hauptthemen laut MEDLINE: Harm Reduction, Androgens, Doping in Sports. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Doping Authority Netherlands.
Abstract (Originalsprache)
Objective
Androgen abuse for performance- and image-enhancement is increasing despite preventive efforts, yet no controlled trials have evaluated harm reduction strategies. This trial assessed whether a harm reduction intervention could reduce androgen abuse in males.
Design
Historically controlled trial.
Methods
This 1-year prospective intervention study included 99 male amateur athletes planning to start an androgen cycle. Outcomes were compared to a historical cohort study (n = 100) from our research group receiving no intervention. The intervention comprised individualized counseling and medical assessments. Primary outcomes included cumulative androgen dose, cycle duration, and weekly dosage. Secondary outcomes included within-participant deviation from planned abuse.
Results
Baseline characteristics were largely comparable, although intervention participants reported slightly more weekly training time and lower intended cumulative cycle dose. Twelve percent refrained from initiating a cycle due to the intervention. The mean cumulative androgen dose was 13 087 (95% CI −16 564 to −9609) mg lower in the intervention group (6323 ± 5229 mg) compared to controls (19 410 ± 16 497 mg). Within-person differences showed an average reduction of 8729 (95% CI −11 297 to −6287) mg in the intervention group compared to controls. Multivariable regression confirmed that the interventions' effect was independent of baseline differences. No significant enabling effect was observed.
Conclusion
This is the first controlled study to demonstrate that a harm reduction intervention can reduce androgen exposure among men planning to abuse androgens. These findings support harm reduction as a promising strategy to mitigate health risks associated with androgen abuse. Future studies should confirm generalizability and monitor for potential enabling effects. Clinical trial registration number Registration number P2117, study number NL77191.028.21.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Spaarne Gasthuis, Boerhaavelaan 22, Haarlem 2035 RC, the Netherlands.
- Department of Endocrinology and Metabolism, Amsterdam UMC, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands.
- Department of Performance and Image-Enhancing Drugs Research, Android Health Clinic, Leidse Rijn 31, Utrecht 3454 PZ, the Netherlands.
- Department of Internal Medicine, Zaandam Medical Centre, Koningin Julianaplein 58, Zaandam 1502 DV, the Netherlands.
ORCID-Profile: Tijs Johannes Verdegaal, Willem de Ronde
Förderung
- Doping Authority Netherlands
Zitieren
APA
Verdegaal, T. J., de Ronde, W., Jansen, M., Bond, P., & Smit, D. L. (2026). The efficacy of a harm reduction intervention for androgen abuse: a historically controlled trial. European Journal of Endocrinology, 194(2), 69-79. https://doi.org/10.1093/ejendo/lvag002
Vancouver
Verdegaal TJ, de Ronde W, Jansen M, Bond P, Smit DL. The efficacy of a harm reduction intervention for androgen abuse: a historically controlled trial. European Journal of Endocrinology. 2026;194(2):69-79. doi:10.1093/ejendo/lvag002
BibTeX
@article{Verdegaal2026,
author = {Verdegaal, Tijs Johannes and de Ronde, Willem and Jansen, Manon and Bond, Peter and Smit, Diederik Laurens},
title = {The efficacy of a harm reduction intervention for androgen abuse: a historically controlled trial},
journal = {European Journal of Endocrinology},
year = {2026},
volume = {194},
number = {2},
pages = {69--79},
doi = {10.1093/ejendo/lvag002}
}
EUVIMED